ArticleJournal of the National Cancer Institute2023

Re: Suppressing c-FOS expression by G-quadruplex ligands inhibits osimertinib-resistant non-small cell lung cancers.

Steven Lehrer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.